| Report ID |
98763 |
| Drug Identification Number |
02242763 |
| Brand name |
RILUTEK |
| Common or Proper name |
Rilutek |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
RILUZOLE |
| Strength(s) |
50MG |
| Dosage form(s) |
TABLET |
| Route of administration |
ORAL |
| Packaging size |
60 |
| ATC code |
N07XX |
| ATC description |
OTHER NERVOUS SYSTEM DRUGS |
| Reason for shortage |
Shortage of an inactive ingredient or component. |
| Anticipated start date |
2019-12-16 |
| Actual start date |
|
| Estimated end date |
2021-08-31 |
| Actual end date |
|
| Shortage status |
Actual shortage |
| Updated date |
2021-01-27 |
| Company comments |
The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. |
| Health Canada comments |
|
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
